• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有难治性川崎病的持续性关节炎特征:一项单中心回顾性研究。

Characteristics of persistent arthritis with refractory Kawasaki disease: a single-center retrospective study.

机构信息

Department of Paediatrics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, 236-0004, Japan.

Department of Paediatrics, Nagasaki University Hospital, Nagasaki, Japan.

出版信息

Sci Rep. 2023 Jun 19;13(1):9890. doi: 10.1038/s41598-023-36308-9.

DOI:10.1038/s41598-023-36308-9
PMID:37336934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10279726/
Abstract

Arthritis is one complication of Kawasaki disease (KD); however, the clinical features of arthritis in KD have not been well clarified. We retrospectively investigated the characteristics of persistent arthritis beyond the subacute phase of KD. In this cohort, 49 of 243 patients (20%) developed arthritis, with 33 patients (14%) experiencing persistent arthritis. Among these 33 patients, 31 (94%) had complete KD. Thirty (91%) were resistant to first intravenous immunoglobulin, and 15 (45%) required additional infliximab. Five patients (15%) developed coronary artery lesions, and 24 (73%) had oligoarthritis, mainly in large lower-extremity joints. Twenty-four patients (73%) complained of arthralgia. At arthritis onset, 16 patients (48%) presented with fever, including recurrent fever in 10 patients. Serum C-reactive protein concentration in patients with active arthritis significantly increased compared with after acute KD treatment (2.4 vs. 0.7 mg/dL, p < 0.001). Serum matrix metalloproteinase-3, a biomarker of arthritis, was significantly higher in patients with active arthritis than in remission (93.7 vs. 20.3 ng/mL, p < 0.001). Thirty (91%) and 14 (42%) patients, respectively, were treated with non-steroidal anti-inflammatory drugs and prednisolone, and they completely recovered. To summarize, persistent arthritis is a common complication in refractory KD, and adequate diagnosis and treatment are necessary.

摘要

关节炎是川崎病(KD)的一种并发症;然而,KD 关节炎的临床特征尚未得到充分阐明。我们回顾性调查了 KD 亚急性期后持续性关节炎的特征。在该队列中,243 例患者中有 49 例(20%)发生关节炎,其中 33 例(14%)为持续性关节炎。在这 33 例患者中,31 例(94%)患有完全性 KD。30 例(91%)对首次静脉注射免疫球蛋白耐药,15 例(45%)需要额外使用英夫利昔单抗。5 例(15%)发生冠状动脉病变,24 例(73%)为少关节炎,主要累及大下肢关节。24 例(73%)诉有关节痛。关节炎发作时,16 例(48%)伴有发热,其中 10 例为反复发热。与急性 KD 治疗后相比,活动性关节炎患者的血清 C 反应蛋白浓度显著升高(2.4 比 0.7 mg/dL,p<0.001)。活动性关节炎患者的血清基质金属蛋白酶-3(关节炎的生物标志物)显著高于缓解期(93.7 比 20.3 ng/mL,p<0.001)。分别有 30(91%)和 14(42%)例患者接受非甾体抗炎药和泼尼松龙治疗,他们完全康复。总之,持续性关节炎是难治性 KD 的常见并发症,需要充分诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/10279726/014e7e34c79f/41598_2023_36308_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/10279726/0966d9f7d84b/41598_2023_36308_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/10279726/2341d2dbae91/41598_2023_36308_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/10279726/f7eac9ea7223/41598_2023_36308_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/10279726/014e7e34c79f/41598_2023_36308_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/10279726/0966d9f7d84b/41598_2023_36308_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/10279726/2341d2dbae91/41598_2023_36308_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/10279726/f7eac9ea7223/41598_2023_36308_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42c3/10279726/014e7e34c79f/41598_2023_36308_Fig4_HTML.jpg

相似文献

1
Characteristics of persistent arthritis with refractory Kawasaki disease: a single-center retrospective study.具有难治性川崎病的持续性关节炎特征:一项单中心回顾性研究。
Sci Rep. 2023 Jun 19;13(1):9890. doi: 10.1038/s41598-023-36308-9.
2
Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience.澳大利亚三级医疗机构中川崎病的诊断、治疗及预后:三年经验回顾
J Paediatr Child Health. 2005 Sep-Oct;41(9-10):495-9. doi: 10.1111/j.1440-1754.2005.00690.x.
3
Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.比较静脉注射免疫球蛋白和低剂量与高剂量阿司匹林治疗川崎病儿童复发性发热的风险。
JAMA Netw Open. 2020 Jan 3;3(1):e1918565. doi: 10.1001/jamanetworkopen.2019.18565.
4
A Sri Lankan infant with immunoglobulin resistant incomplete Kawasaki disease with a vesicular psoriasiform rash, hypertension and late onset small joint arthritis: a case report.一名斯里兰卡婴儿患有免疫球蛋白耐药性不完全川崎病,伴有水疱样银屑病样皮疹、高血压和迟发性小关节关节炎:一例报告。
BMC Pediatr. 2022 Jul 23;22(1):444. doi: 10.1186/s12887-022-03510-z.
5
Clinico-laboratory profile of Kawasaki disease with arthritis in children.川崎病关节炎患儿的临床-实验室特征。
Eur J Pediatr. 2020 Jun;179(6):875-879. doi: 10.1007/s00431-020-03582-y. Epub 2020 Jan 23.
6
Clinical symptoms of patients with Kawasaki disease include smoldering fever.川崎病患者的临床症状包括低热。
Pediatr Int. 2023 Jan-Dec;65(1):e15541. doi: 10.1111/ped.15541.
7
[The role of immunosuppressive agents in Kawasaki disease: a discussion of two cases].[免疫抑制剂在川崎病中的作用:两例病例讨论]
Arch Pediatr. 2013 Jul;20(7):748-53. doi: 10.1016/j.arcped.2013.04.002. Epub 2013 May 18.
8
Has joint involvement lessened in Kawasaki disease?川崎病的关节受累情况是否有所减轻?
Reumatol Clin. 2017 May-Jun;13(3):145-149. doi: 10.1016/j.reuma.2016.04.004. Epub 2016 Jun 2.
9
Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin.川崎病患者接受英夫利昔单抗和静脉注射免疫球蛋白治疗后的免疫监测。
Clin Exp Immunol. 2013 Dec;174(3):337-44. doi: 10.1111/cei.12182.
10
Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.C 反应蛋白水平在预测川崎病患儿对额外静脉注射免疫球蛋白治疗无反应中的重要性:一项回顾性研究。
Clin Drug Investig. 2011;31(3):191-9. doi: 10.2165/11538910-000000000-00000.

引用本文的文献

1
Arthritis associated with Kawasaki disease after initial combination therapy with cyclosporine: a case report.环孢素初始联合治疗后与川崎病相关的关节炎:一例报告
Transl Pediatr. 2025 Aug 31;14(8):2042-2046. doi: 10.21037/tp-2025-176. Epub 2025 Aug 24.

本文引用的文献

1
Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018.2017-2018 年日本全国川崎病患者的流行病学、治疗方法和心脏并发症调查。
J Pediatr. 2020 Oct;225:23-29.e2. doi: 10.1016/j.jpeds.2020.05.034. Epub 2020 May 23.
2
Clinico-laboratory profile of Kawasaki disease with arthritis in children.川崎病关节炎患儿的临床-实验室特征。
Eur J Pediatr. 2020 Jun;179(6):875-879. doi: 10.1007/s00431-020-03582-y. Epub 2020 Jan 23.
3
Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population.
北美人群川崎病冠状动脉瘤风险模型的建立与验证。
J Am Heart Assoc. 2019 Jun 4;8(11):e011319. doi: 10.1161/JAHA.118.011319.
4
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.2019 年美国风湿病学会/关节炎基金会治疗幼年特发性关节炎指南:非系统性多关节炎、骶髂关节炎和附着点炎的治疗方法。
Arthritis Care Res (Hoboken). 2019 Jun;71(6):717-734. doi: 10.1002/acr.23870. Epub 2019 Apr 25.
5
Prevalence and characteristics of arthritis in Kawasaki disease: a Chinese cohort study.川崎病关节炎的患病率及特征:一项中国队列研究。
Clin Exp Med. 2019 May;19(2):167-172. doi: 10.1007/s10238-019-00547-w. Epub 2019 Feb 6.
6
Kawasaki disease-related arthritis with synovial involvement.川崎病相关关节炎伴滑膜受累。
Pediatr Int. 2019 Jan;61(1):98-99. doi: 10.1111/ped.13721. Epub 2018 Dec 11.
7
Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018.《2018年青少年特发性关节炎临床实践指南》
Mod Rheumatol. 2019 Jan;29(1):41-59. doi: 10.1080/14397595.2018.1514724. Epub 2018 Oct 29.
8
Arthritis in Kawasaki disease: A poorly recognised manifestation.川崎病中的关节炎:一种未得到充分认识的表现。
J Paediatr Child Health. 2018 Dec;54(12):1371-1374. doi: 10.1111/jpc.14102. Epub 2018 Jun 26.
9
Recurrence of Fever After Initial Intravenous Immunoglobulin Treatment in Children With Kawasaki Disease.川崎病患儿初次静脉注射免疫球蛋白治疗后发热复发
Clin Pediatr (Phila). 2018 Feb;57(2):189-192. doi: 10.1177/0009922817694459. Epub 2017 Feb 1.
10
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.川崎病的诊断、治疗和长期管理:美国心脏协会发布的一份面向医疗保健专业人员的科学声明。
Circulation. 2017 Apr 25;135(17):e927-e999. doi: 10.1161/CIR.0000000000000484. Epub 2017 Mar 29.